Keele Medicines Management Services

Keele Medicines Management Services offers a range of tailored, prescribing support solutions to the NHS.  Working with medicines management teams, commissioners and GPs, our services include prescribing data analysis, medicines management education, and critical appraisal/commissioning support services.

This site can be navigated using the links on the left hand menu, however you may find the following two pages of particular interest and we would also encourage you to keep up to date with our latest announcements on Twitter:

West Midlands users can log-in by clicking here

Pharmacy Prospectus Picture-09 Find out more about Keele Medicines Management Services

‌Download our brochure or access the "About Us" pages on this website to learn more about Keele Medicines Management Services

   News: Latest medicines optimisation reports now available Posted on 21 May 2013 The final quarter's medicines optimisation spreadsheets for 2012-13 is now available. Find out more...   News: Latest financial and prescribing changes report now available Posted on 17 May 2013 The final quarter's Financial and General Prescribing Report for 2012-13 is now available. Find out more...   News: Monthly Script now available Posted on 15 May 2013 The May-13 Monthly Script is now available on-line for subscribed healthcare professionals. The newsletter provides a round-up of developments in five key areas of primary care prescribing. Find out more... Actions for Commissioning Teams Logo ACT: Pain Management

Published: 4 April 2013
An Actions for Commissioning Teams package is now available to support pain management.  Access it via your PCT log-in page or the open-access resources page.

 Bridge Stairway at Hospital Site   News: Mental Health Indicators Q3 2012-13 Posted on 19 March 2013 The mental health prescribing indicators for Q3 of 2012-13 are now available online for West Midlands users. Read more... QIPP   Prescribing Information to Support QIPP document available Posted on 30 January 2013 The report includes a breakdown of key therapeutic topics recognised by the NPC as having significant potential for making a contribution to the challenge posed by QIPP.